Literature DB >> 19647021

Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.

Ekaterina Ivanova-Todorova1, Ivan Bochev, Milena Mourdjeva, Rumen Dimitrov, Dimitar Bukarev, Stanimir Kyurkchiev, Petar Tivchev, Iskra Altunkova, Dobroslav Stanimirov Kyurkchiev.   

Abstract

Both mesenchymal stem cells (MSCs) and dendritic cells (DCs) are engaged in the regulation of the immune response parallel to their numerous functions. The main objective of this study was to compare the effects of mesenchymal stem cells isolated from human adipose tissue or human bone marrow on the expression of specific cell surface markers as well as the secretion of some cytokines by monocyte-derived dendritic cells. The set of methods used includes cell cultures, magnetic beads isolation of cells, flow cytometry, ELISA and proteome profiler kit assays. The results obtained show that MSCs isolated from human adipose tissue are more potent immunomodulators of differentiation of human DCs in comparison to the bone marrow-derived MSCs. In both cases the percentages of CD14+ cells were increased in co-cultures of MSCs and DCs and at the same time down-regulated the expression of CD80, CD86 and CD83 as in all experiments the effect of adipose tissue MSCs was stronger. Similarly, the secretion of IL-10 by dendritic cells was up-regulated in co-cultures of MSCs and dendritic cells and the effect was stronger when adipose tissue-derived MSCs were used. Taken together all results presented reveal the higher potential of the adipose tissue-derived MSCs to inhibit the differentiation and expression of functionally important co-stimulatory molecules on the surface of monocyte-derived dendritic cells than the bone marrow-derived MSCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647021     DOI: 10.1016/j.imlet.2009.07.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  78 in total

1.  Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.

Authors:  Sara M Melief; Jaap Jan Zwaginga; Willem E Fibbe; Helene Roelofs
Journal:  Stem Cells Transl Med       Date:  2013-05-21       Impact factor: 6.940

2.  Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC).

Authors:  Erika Moravcikova; E Michael Meyer; Mirko Corselli; Vera S Donnenberg; Albert D Donnenberg
Journal:  Cytometry A       Date:  2018-09-13       Impact factor: 4.355

Review 3.  Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells.

Authors:  Ênio José Bassi; Danilo Candido de Almeida; Pedro Manoel Mendes Moraes-Vieira; Niels Olsen Saraiva Câmara
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

Review 4.  Secretion of immunoregulatory cytokines by mesenchymal stem cells.

Authors:  Dobroslav Kyurkchiev; Ivan Bochev; Ekaterina Ivanova-Todorova; Milena Mourdjeva; Tsvetelina Oreshkova; Kalina Belemezova; Stanimir Kyurkchiev
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

5.  Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.

Authors:  Cedric Menard; Luciano Pacelli; Giulio Bassi; Joelle Dulong; Francesco Bifari; Isabelle Bezier; Jasmina Zanoncello; Mario Ricciardi; Maelle Latour; Philippe Bourin; Hubert Schrezenmeier; Luc Sensebé; Karin Tarte; Mauro Krampera
Journal:  Stem Cells Dev       Date:  2013-02-25       Impact factor: 3.272

6.  Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury.

Authors:  Anna Badner; Reaz Vawda; Alex Laliberte; James Hong; Mirriam Mikhail; Alejandro Jose; Rachel Dragas; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

Review 7.  Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants.

Authors:  Ching-Shwun Lin; Guiting Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2012-07-03       Impact factor: 3.272

8.  Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial.

Authors:  Mariano García-Arranz; Maria Dolores Herreros; Carolina González-Gómez; Paloma de la Quintana; Héctor Guadalajara; Tihomir Georgiev-Hristov; Jacobo Trébol; Damián Garcia-Olmo
Journal:  Stem Cells Transl Med       Date:  2016-07-13       Impact factor: 6.940

9.  Rat adipose-derived stem cells express low level of α-Gal and are dependent on CD59 for protection from human xenoantibody and complement-mediated lysis.

Authors:  Yu Jia; Yue Zhao; Lu Wang; Ying Xiang; Song Chen; Chang-Sheng Ming; Cong-Yi Wang; Gang Chen
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

10.  Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages.

Authors:  Kazuhiro Furuhashi; Naotake Tsuboi; Asuka Shimizu; Takayuki Katsuno; Hangsoo Kim; Yosuke Saka; Takenori Ozaki; Yoshikazu Sado; Enyu Imai; Seiichi Matsuo; Shoichi Maruyama
Journal:  J Am Soc Nephrol       Date:  2013-03-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.